Cure Brain Cancer Foundation CEO Lance Kawaguchi rang the bell to open trading on the Nasdaq stock exchange on Friday morning, 2 December.
The Foundation announced the establishment of an independent U.S. affiliate that will widely increase the impact of Australia’s leading non-profit in brain cancer research and patient advocacy. The ringing of the bell coincides with the November incorporation, in Maryland, of Cure Brain Cancer Foundation America, Inc.
“It’s a privilege to have the chance to ring the opening bell here at Nasdaq, which is recognized globally for being the home of innovators, disruptors and change-makers, especially of new technologies and services,” said Mr. Kawaguchi. “Cure Brain Cancer Foundation funds our own innovators: cancer scientists, research-physicians and ground breaking, innovative early-stage biotechnology companies.”
